Literature DB >> 21067739

Occurrence of and risk factors for complications after endoscopic dilation in eosinophilic esophagitis.

Kee Wook Jung1, Nancy Gundersen, Jana Kopacova, Amindra S Arora, Yvonne Romero, David Katzka, Dawn Francis, Julie Schreiber, Ross A Dierkhising, Nicholas J Talley, Thomas C Smyrk, Jeffrey A Alexander.   

Abstract

BACKGROUND: Several small series have suggested an increased risk of complications associated with esophageal dilation in patients with eosinophilic esophagitis (EoE).
OBJECTIVE: To quantitate the risk and identify risk factors for esophageal complications in dilation in EoE patients.
DESIGN: Retrospective, uncontrolled, single-center study.
SETTING: Tertiary referral hospital. PATIENTS: A total of 161 EoE patients (mean ± standard deviation age 44.3 ± 15.3 years, 112 men, 49 women, 150 white patients, 10 unknown, 1 Asian).
INTERVENTIONS: Through-the-scope balloon or Savary dilation of EoE. MAIN OUTCOME MEASUREMENTS: The rate of complications defined as deep mucosal tear, major bleeding, or perforation, and determination of risk factors for complications.
RESULTS: A total of 293 dilations were performed in 161 patients. Complications reported were deep mucosal tear in 9.2% (n = 27), major bleeding in 0.3% (n = 1), and immediate perforation in 1.0% (n = 3). All patients with perforations were successfully treated medically without surgery (mean ± standard deviation hospital stay 5.3 ± 3.2 days). Factors associated with an increased risk of complications were luminal narrowing in the upper (odds ratio [OR], 5.62; 95% CI, 2.07-15.26; P < .001) and middle third of the esophagus (OR, 4.93; 95% CI, 1.64-14.83; P < .005) compared with lower third, luminal stricture unable to be traversed with a standard upper endoscope (OR, 2.48; 95% CI, 1.06-5.83; P = .037), and use of Savary dilator (OR, 2.63; 95% CI, 1.18-5.83; P = .018). LIMITATIONS: Retrospective design, uncontrolled study.
CONCLUSIONS: Deep mucosal tears are common after dilation (9%), but the risk of immediate transluminal perforation with EoE is approximately 1%. The risk of severe complications is increased in patients with more proximal stricture and strictures that initially prevent endoscope passage.
Copyright © 2011 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21067739     DOI: 10.1016/j.gie.2010.09.036

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  33 in total

Review 1.  Diagnosis and management of eosinophilic esophagitis.

Authors:  Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2012-06-19       Impact factor: 11.382

Review 2.  Management of proton pump inhibitor responsive-esophageal eosinophilia and eosinophilic esophagitis: controversies in treatment approaches.

Authors:  Bharati Kochar; Evan S Dellon
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-09-12       Impact factor: 3.869

Review 3.  Management of pediatric eosinophilic esophagitis: an update.

Authors:  Seema Khan
Journal:  Paediatr Drugs       Date:  2012-02-01       Impact factor: 3.022

4.  Dysphagia and health-related quality of life in patients with eosinophilic esophagitis: a long-term follow-up.

Authors:  Helen Larsson; Karin Bergman; Caterina Finizia; Leif Johansson; Mogens Bove; Henrik Bergquist
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-08       Impact factor: 2.503

5.  Biodegradable stent or balloon dilatation for benign oesophageal stricture: pilot randomised controlled trial.

Authors:  Anjan Dhar; Helen Close; Yirupaiahgari K Viswanath; Colin J Rees; Helen C Hancock; A Deepak Dwarakanath; Rebecca H Maier; Douglas Wilson; James M Mason
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

Review 6.  Eosinophilic esophagitis: current treatment.

Authors:  Matthew Redd; Ron Schey
Journal:  Dig Dis Sci       Date:  2012-09-22       Impact factor: 3.199

7.  Outcomes of Esophageal Dilation in Eosinophilic Esophagitis: Safety, Efficacy, and Persistence of the Fibrostenotic Phenotype.

Authors:  Thomas M Runge; Swathi Eluri; Cary C Cotton; Caitlin M Burk; John T Woosley; Nicholas J Shaheen; Evan S Dellon
Journal:  Am J Gastroenterol       Date:  2016-01-12       Impact factor: 10.864

Review 8.  Advances in clinical management of eosinophilic esophagitis.

Authors:  Evan S Dellon; Chris A Liacouras
Journal:  Gastroenterology       Date:  2014-08-07       Impact factor: 22.682

Review 9.  Eosinophilic esophagitis.

Authors:  Evan S Dellon
Journal:  Gastroenterol Clin North Am       Date:  2012-12-27       Impact factor: 3.806

10.  Temporal trends in the relative prevalence of dysphagia etiologies from 1999-2009.

Authors:  Trilokesh Kidambi; Erin Toto; Nancy Ho; Tiffany Taft; Ikuo Hirano
Journal:  World J Gastroenterol       Date:  2012-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.